Home   >  
MAPK Pathway
  >  
p38 MAPK

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

p38 MAPK

Chemical Structure Cat. No. Product Name CAS No.
SD-06 Chemical Structure
 BCP21625 SD-06 271576-80-8
SD-06 is a MAPK p38 alpha inhibitor for the treatment of arthritis.
SB202190 HCl Chemical Structure
 BCP21617 SB202190 HCl 350228-36-3
SB 202190 inhibits p38 and p38β2 with IC50 values of 50 nM and 100 nM. respectively.
R1487 Chemical Structure
 BCP29574 R1487 449811-92-1
R1487 is a p38 MAP kinase inhibitor with an IC50 of 10nM.
UM164 Chemical Structure
 BCP29207 UM164 903564-48-7
UM164 is a movel potent, dual c-Src/p38 with Kd of 2.7 nM (c-Src), potently inhibits both p38α and p38β; inhibits c-Src autophosphorylation in TNBC cell lines.
VX 702 Chemical Structure
 BCP28564 VX 702 745833-23-2
VX-702, one of a series of second-generation, is an orally active p38 MAP kinase inhibitors, for the potential treatment of inflammation, rheumatoid arthritis and cardiovascular diseases.
SB-681323 Chemical Structure
 BCP23819 SB-681323 444606-18-2
SB-681323, also known as Dilmapimod and GW-681323 , is p38 MAPK inhibitor.
p38 MAPK-IN-1 Chemical Structure
 BCP24818 p38 MAPK-IN-1 1006378-90-0
p38 MAPK-IN-1 is a novel potent and selective inhibitor of p38 MAPK with IC50 of 68 nM, shows sustained levels, low clearance and good bioavailability.
Dehydrocorydaline chloride Chemical Structure
 BCP24819 Dehydrocorydaline chloride 10605-03-5
Dehydrocorydaline chloride is an alkaloidal that has anti-inflammatory and anti-cancer activities.
Acumapimod Chemical Structure
 BCP29101 Acumapimod 836683-15-9
Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 μM for p38α.
TA-01 Chemical Structure
 BCP24229 TA-01 1784751-18-3
TA-01 is a potent CK1 and p38 MAPK inhibitor, with IC50s of 6.4 nM, 6.8 nM, 6.7 nM for CK1ε, CK1δ and p38 MAPK, respectively.
123下一页共 29 条记录 1 / 3 页 
0086-13720134139